Invention Grant
US09149459B2 Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
有权
鞘氨醇1磷酸受体调节剂及其用于治疗肌肉炎症的用途
- Patent Title: Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
- Patent Title (中): 鞘氨醇1磷酸受体调节剂及其用于治疗肌肉炎症的用途
-
Application No.: US13055206Application Date: 2009-07-22
-
Publication No.: US09149459B2Publication Date: 2015-10-06
- Inventor: Syed Sohail Ahmed , Marco Londei , Timothy Wright , Peter Gergely
- Applicant: Syed Sohail Ahmed , Marco Londei , Timothy Wright , Peter Gergely
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent James Lynch
- Priority: EP08161005 20080723
- International Application: PCT/EP2009/059440 WO 20090722
- International Announcement: WO2010/010127 WO 20100128
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A01N43/40 ; A61K31/44 ; A61K31/397
Abstract:
The use of an S1P receptor modulator of the formula (Ia) or (Ib) wherein the meaning of the different residues is that indicated in claim 14, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis, dermatomyositis and nerve-muscle diseases e.g. muscular dystrophies and inclusion body myositis.
Public/Granted literature
- US20110124620A1 SPHINGOSINE 1 PHOSPHATE RECEPTOR MODUATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION Public/Granted day:2011-05-26
Information query
IPC分类:
